Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Zyvox/ Linezolid · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Zyvox® / Linezolid | DRUG | - |
Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: * Hospitalized/chronic care pediatric patients (birth through 17 years) * Known infections due to vancomycin-resistant enterococcus sp...
Top 20 of 28 competitors
Zyvox, also known as linezolid, is an antibiotic used to treat bacterial infections. It is being studied for use in pediatric patients with infections caused by vancomycin-resistant Enterococcus, a specific type of bacteria. The drug is in Phase 3 clinical development for this indication.
Zyvox (linezolid) is a small molecule antibiotic that targets bacterial infections. It works by inhibiting bacterial protein synthesis, which stops the growth and spread of bacteria. This mechanism makes it effective against certain resistant bacteria, such as vancomycin-resistant Enterococcus.
Zyvox (linezolid) is developed by Pfizer, Inc., a pharmaceutical company traded on the New York Stock Exchange under the ticker symbol PFE. Pfizer is conducting clinical trials to evaluate the drug's safety and efficacy in treating bacterial infections.
Zyvox (linezolid) is in Phase 3 clinical development for the treatment of bacterial infections. It is an investigational drug and has not been approved by regulatory authorities for this specific use. The Phase 3 trial has been completed.
Zyvox (linezolid) has one completed Phase 3 clinical trial, identified as NCT00035854. This trial studied the drug in pediatric patients with infections due to vancomycin-resistant Enterococcus. The trial enrolled 13 participants in the United States and was not blinded or controlled.
Yes, Zyvox is the brand name for linezolid. The drug is referred to by both names in clinical and medical contexts. Pfizer, Inc. develops Zyvox (linezolid) as a small molecule antibiotic for treating bacterial infections.